Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 186313011000036110 | Gabahexal (gabapentin 300 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 186314011000036112 | Gabahexal 300 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Gabahexal 300 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Gabahexal 300 mg capsule | Is a | Gabahexal | true | Inferred relationship | Some | ||
| Gabahexal 300 mg capsule | Is a | gabapentin 300 mg capsule | true | Inferred relationship | Some | ||
| Gabahexal 300 mg capsule | has intended active ingredient | gabapentin | true | Inferred relationship | Some | 1657151934 | |
| Gabahexal 300 mg capsule | has Australian BoSS | gabapentin | true | Inferred relationship | Some | 1657151934 | |
| Gabahexal 300 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 1657151935 | |
| Gabahexal 300 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Gabahexal 300 mg capsule, 100 | has TPUU | True | Gabahexal 300 mg capsule | Inferred relationship | Some | 1 |
| Gabahexal 300 mg capsule, 100, blister pack | has TPUU | True | Gabahexal 300 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Victoria reportable Schedule 4 medications reference set
South Australia reportable Schedule 4 medications reference set
Queensland Health QScript Schedule 4 monitored medicines reference set
Northern Territory Reportable Schedule 4 medications reference set
ACT Reportable Schedule 4 medications reference set
Trade product unit of use reference set
FHIR